Serotonergic vulnerability and depression: assumptions, experimental evidence and implications. (Q36679249)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Serotonergic vulnerability and depression: assumptions, experimental evidence and implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

Jans LA

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Markus CR

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

Blokland A

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

language of work or name

English

0 references

publication date

12 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

522-543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001920

22 December 2019

exact match

0 references

cites work

Preclinical models: status of basic research in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

A review of the role of serotonin receptors in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Letter: Total and free plasma-tryptophan concentration and oral contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

"Serotonin Depression"—A Biochemical Subgroup Within the Affective Disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

PET imaging of serotonin 1A receptor binding in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Acute tryptophan depletion in healthy young women with a family history of major affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Mood effects of 24-hour tryptophan depletion in healthy first-degree relatives of patients with affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Tryptophan depletion and depressive vulnerability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Recovery from major depression is not associated with normalization of serotonergic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

State and trait abnormalities in serotonin function in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Can stress cause depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Predictors of mood response to acute tryptophan depletion. A reanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of acute tryptophan depletion on mood and cortisol release in first-degree relatives of type I and type II bipolar patients and healthy matched controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cognition following acute tryptophan depletion: difference between first-degree relatives of bipolar disorder patients and matched healthy control volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Tryptophan, mood, and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Genetic epidemiology of major depression: review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Family history of depression in clinic and community samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Seasonal and nonseasonal depression: how do they differ? Symptom profile, clinical and family history in a general population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Depression spectrum disease, I: The role of gene-environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals--a genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonergic gene expression and depression: implications for developing novel antidepressants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonin-2A-receptor and -transporter polymorphisms: lack of association in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Is there an association between serotonin transporter gene polymorphism and family history of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Genetically driven variation in serotonin uptake: is there a link to affective spectrum, neurodevelopmental, and neurodegenerative disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Variation of serotonergic gene expression: neurodevelopment and the complexity of response to psychopharmacologic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Genetic perspectives on the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

A common C-1018G polymorphism in the human 5-HT1A receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Reduced serotonin type 1A receptor binding in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Support for the involvement of TPH2 gene in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Synthesis of serotonin by a second tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Tryptophan hydroxylase-2 controls brain serotonin synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Personality as a vulnerability factor to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

A longitudinal twin study of personality and major depression in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neuroticism: a vulnerability marker for depression evidence from a family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Affective state dependence of the Tridimensional Personality Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neurotransmitters, temperament and social functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonergic involvement in the psychosocial dimension of personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Selective alteration of personality and social behavior by serotonergic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The Tridimensional Personality Questionnaire in depression: state versus trait issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Relationship between serotonin and the temperament and character inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Denosologization of biological psychiatry or the specificity of 5-HT disturbances in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

CSF monoamine metabolite concentrations vary according to age, rearing, and sex, and are influenced by the stressor of social separation in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Paternal and maternal genetic and environmental contributions to cerebrospinal fluid monoamine metabolites in rhesus monkeys (Macaca mulatta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Low central nervous system serotonergic activity is traitlike and correlates with impulsive behavior. A nonhuman primate model investigating genetic and environmental influences on neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Gender differences in depression. Critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cross-national epidemiology of major depression and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sex differences in serotonergic activity in dorsal and median raphe nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

A regional study of sex differences in rat brain serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Differences in brain area 5-hydroxytryptamine turnover and rearing behavior in rats and mice of both sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Gender and gonadal status modulation of dorsal raphe nucleus serotonergic neurons. Part I: effects of gender and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sex difference in 5HT2 receptor in the living human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Differences between males and females in rates of serotonin synthesis in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sex differences in diencephalon serotonin transporter availability in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Estrogen receptors in the human forebrain and the relation to neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Estrous cycle modulation of extracellular serotonin in mediobasal hypothalamus: role of the serotonin transporter and terminal autoreceptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Steroid hormone receptors and their regulation by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sex steroid control of mood, mental state and memory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Estrogen, serotonin, and mood disturbance: where is the therapeutic bridge?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Estrogen receptor gene expression in relation to neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Estrogen-serotonin interactions: implications for affective regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neural circuits mediating stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Depression, stress and immunological activation: the role of cytokines in depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The role of prenatal stress in the etiology of developmental behavioural disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal stress and risk for psychopathology: specific effects or induction of general susceptibility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Influence of academic stress and season on 24-hour mean concentrations of ACTH, cortisol, and beta-endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cytokines, stress and depressive illness: brain‐immune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stress and the brain: from adaptation to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The corticosteroid receptor hypothesis of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Long-lasting effects of an acute stress on the neurochemistry and function of 5-hydroxytryptaminergic neurones in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal stress and long-term consequences: implications of glucocorticoid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of glucocorticoids on 5-HT1A presynaptic function in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The impact of stressors on immune and central neurotransmitter activity: bidirectional communication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Corticosteroid-serotonin interactions in depression: a review of the human evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Regulation of corticosteroid receptors in the rat brain: the role of serotonin and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Chronic stress alters synaptic terminal structure in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stress effects on morphology and function of the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Why stress is bad for your brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stress and hippocampal neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stress and hippocampal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stress, genes and the mechanism of programming the brain for later life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal stress in rats predicts immobility behavior in the forced swim test. Effects of a chronic treatment with tianeptine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Does prenatal stress impair coping and regulation of hypothalamic-pituitary-adrenal axis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal stress and neonatal rat brain development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Maternal stress induces synaptic loss and developmental disabilities of offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effect of prenatal stress on opioid component of exploration in different experimental situations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal stress differentially affects habituation of corticosterone responses to repeated stress in adult male and female rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Pulsatile rhythms of adrenocorticotropin (ACTH) and cortisol in women with endogenous depression: evidence for increased ACTH pulse frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The developmental role of serotonin: news from mouse molecular genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Decreased hypothalamic serotonin levels in adult rats treated neonatally with clomipramine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of prenatal 5-methoxytryptamine and parachlorophenylalanine on serotonergic uptake and behavior in the neonatal rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Administration of tryptophan-enriched diets to pregnant rats retards the development of the serotonergic system in their offspring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal cocaine exposure disrupts the development of the serotonergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Reduced serotonin release and serotonin uptake sites in the rat nucleus accumbens and striatum after prenatal cocaine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of gestational exposure to monoamine oxidase inhibitors in rats: preliminary behavioral and neurochemical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Maternal adversity, glucocorticoids and programming of neuroendocrine function and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Importance of studying the contributions of early adverse experience to neurobiological findings in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Brain 5-HT receptor system in the stressed infant rat: implications for vulnerability to substance abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Social regulation of the cortisol levels in early human development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Quality of early care and buffering of neuroendocrine stress reactions: potential effects on the developing human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neonatal maternal separation reduces hippocampal mossy fiber density in adult Long Evans rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Early environmental regulation of forebrain glucocorticoid receptor gene expression: implications for adrenocortical responses to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sex differences in the effects of neonatal handling on the animal's response to stress and the vulnerability for depressive behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Early deprivation under specific conditions leads to reduced interest in reward in adulthood in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The impaired coping induced by early deprivation is reversed by chronic fluoxetine treatment in adult fischer rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Hypothalamic-pituitary-adrenal function in chronic intermittently cold-stressed neonatally handled and non handled rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Foster litters prevent hypothalamic-pituitary-adrenal axis sensitization mediated by neonatal maternal separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Long-term effects of neonatal maternal deprivation and ACTH on hippocampal mineralocorticoid and glucocorticoid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stress in early life inhibits neurogenesis in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Is impaired neurogenesis relevant to the affective symptoms of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Early life experience alters response of adult neurogenesis to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sensitization associated with stressors and cytokine treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cytokines as a stressor: implications for depressive illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cytokines and depression: the need for a new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stress, depression, and the role of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Dynamic regulation of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cytokines and major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Impaired natural killer cell activity among depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Evidence for an immune response in major depression: a review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Major depression and activation of the inflammatory response system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Depression in medical illness: the role of the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Acute inflammation and negative mood: mediation by cytokine activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cytokine-associated emotional and cognitive disturbances in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Mild acute inflammatory stimulation induces transient negative mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cytokines, "depression due to a general medical condition," and antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Endogenous kynurenines as targets for drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Lowered Serum Dipeptidyl Peptidase IV Activity is Associated with Depressive Symptoms and Cytokine Production in Cancer Patients Receiving Interleukin-2-Based Immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Regulation of the human serotonin transporter by interleukin-1 beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Enhancement of serotonin transporter function by tumor necrosis factor alpha but not by interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prevalence, etiology, and treatment of depression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Murine tumor necrosis factor-alpha sensitizes plasma corticosterone activity and the manifestation of shock: modulation by histamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Phenotypic plasticity of CRF neurons during stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Long-lasting effects of (+/-)3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Mood state and brain electric activity in ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Recreational ecstasy use and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Psychopathology in hospitalized alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonin and alcohol intake, abuse, and dependence: findings of animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonin and alcohol intake, abuse, and dependence: clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Reduced central serotonin transporters in alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The role of free serum tryptophan in the biphasic effect of acute ethanol administration on the concentrations of rat brain tryptophan, 5-hydroxytryptamine and 5-hydroxyindol-3-ylacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Ethanol increases rat liver tryptophan oxygenase: evidence for corticosterone mediation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prospective study of alcoholism treatment. Eight-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Exploring the association between cannabis use and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Involvement of 5-hydroxytryptamine neuronal system in Delta(9)-tetrahydrocannabinol-induced impairment of spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Altered responsiveness of serotonin receptor subtypes following long-term cannabinoid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Monoaminergic regulation of neuroendocrine function and its modification by cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Repeated cocaine administration reduces 5-HT1A-mediated prolactin secretion in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Genetics of emotional regulation: the role of the serotonin transporter in neural function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Early experience and serotonin transporter gene variation interact to influence primate CNS function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonin transporter genetic variation and the response of the human amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

A susceptibility gene for affective disorders and the response of the human amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Association of a functional polymorphism in the serotonin transporter gene with abnormal emotional processing in ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Acute dietary tryptophan depletion impairs maintenance of "affective set" and delayed visual recognition in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

A relationship between serotonin transporter genotype and in vivo protein expression and alcohol neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Selective genotyping for the role of 5-HT2A, 5-HT2C, and GABA alpha 6 receptors and the serotonin transporter in the level of response to alcohol: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Association between the serotonin transporter promoter polymorphism and personality traits in a primarily female population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Role of the serotonin transporter promoter polymorphism in anxiety-related traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Epistatic effect of genes from the dopamine and serotonin systems on the temperament traits of novelty seeking and harm avoidance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Causal relationship between stressful life events and the onset of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Childhood sexual abuse as a risk factor for depression in women: psychosocial and neurobiological correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal stress in rats: effects on plasma corticosterone, hippocampal glucocorticoid receptors, and maze performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Sex differences in coping and depression among young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Testosterone in utero and at birth dictates how stressful experience will affect learning in adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The contribution of adrenal and reproductive hormones to the opposing effects of stress on trace conditioning in males versus females

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Female rats are more vulnerable than males in an animal model of depression: the possible role of serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Gender differences in the subjective effects of MDMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Insights into the neurobiology of impulsive behavior from serotonin receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

5-HT1B receptor knock out--behavioral consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Tryptophan depletion and its implications for psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonergic regulation of renin and prolactin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neuroendocrine responses to intravenous tryptophan in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Stimulation of Human Prolactin Secretion by Intravenous Infusion of L-Tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neuroendocrine and behavioral effects of dietary tryptophan restriction in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

HPA-Axis hormones and prolactin responses to dextro-fenfluramine in depressed patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Hormone responses to fenfluramine and placebo challenge in endogenous depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonin function in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prolactin response to D-fenfluramine in outpatients with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

D-fenfluramine-induced prolactin and cortisol release in major depression: response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Low-dose citalopram as a 5-HT neuroendocrine probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Brain Serotonin Content: Increase Following Ingestion of Carbohydrate Diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Alpha-lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of food on cortisol and mood in vulnerable subjects under controllable and uncontrollable stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of serotonin transporter promoter polymorphisms on serotonin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Acute tryptophan and serotonin depletion using an optimized tryptophan-free protein-carbohydrate mixture in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Tryptophan depletion causes a rapid lowering of mood in normal males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Rapid depletion of serum tryptophan, brain tryptophan, serotonin and 5-hydroxyindoleacetic acid by a tryptophan-free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Tryptophan depletion during continuous CSF sampling in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The effects of tryptophan depletion on mood and psychiatric symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Relapse of depression after rapid depletion of tryptophan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The mood-lowering effect of tryptophan depletion: possible explanation for discrepant findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Tryptophan depletion in SSRI-recovered depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Acute tryptophan depletion as a model of depressive relapse: behavioural specificity and ethical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The serotonergic hypothesis for depression in Parkinson's disease: an experimental approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

The citalopram challenge test in patients with major depression and in healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Association Between the Tryptophan Hydroxylase Gene and Manic-depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Neuroticism and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Multiple hormone responses to stimulation with dl-fenfluramine in patients with major depression before and after antidepressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

Decreased plasma tryptophan levels in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

The familial aggregation of depressive symptoms, antisocial behavior, and alcohol abuse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

5-Hydroxytryptophol in Human Cerebrospinal Fluid: Conjugation, Concentration Gradient, Relationship to 5-Hydroxyindoleacetic Acid, and Influence of Hereditary Factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Functional polymorphism in the serotonin transporter promoter at the SLC6A4 locus and mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Heritabilities of Common and Measure-Specific Components of the Big Five Personality Factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

The relationship of personality to mood and anxiety states: a dimensional approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

The Tridimensional Personality Questionnaire in major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Temperament and character during the course of unipolar depression among inpatients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Platelet serotonergic markers and Tridimensional Personality Questionnaire measures in a clinical sample

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Harm avoidance and serotonin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Personality disorder scores improve with effective pharmacotherapy of depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Cognitive therapy versus fluoxetine in the treatment of dysthymic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Harm avoidance dimension of the tridimensional personality questionnaire and serotonin-1A activity in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Hippocampal 5-hydroxytryptamine synthesis is greater in female rats than in males and more decreased by the 5-HT1A agonist 8-OH-DPAT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Disrupted 24-hour Patterns of Cortisol Secretion in Psychotic Depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Adoption reverses the long-term impairment in glucocorticoid feedback induced by prenatal stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Programming of brainstem serotonin transporter development by prenatal glucocorticoids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Impaired lymphocyte function in depressive illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Immune and hormonal activity in adults suffering from depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)--neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Brainstem serotonergic neurons in chronic alcoholics with and without the memory impairment of Korsakoff's psychosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

How common is resistance to treatment in recurrent, nonpsychotic geriatric depression?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Knockout Corner: 5-HT1A receptor inactivation: anxiety or depression as a murine experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

The effect of a tryptophan-free diet on prolactin and corticosterone release by serotonergic stimuli

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

The neuroendocrine response to fenfluramine in depressives and normal controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

The effect of buspirone on prolactin and growth hormone secretion in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Comparison of growth hormone and prolactin stimulation induced by chlorimipramine and desimipramine in man in connection with chlorimipramine metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Serotonin indices and impulsivity in normal volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Dietary effects on brain serotonin synthesis: relationship to appetite regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Aromatic amino acids and monoamine synthesis in the central nervous system: influence of the diet

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

alpha-Lactalbumin-enriched low-protein infant formulas: a comparison to breast milk feeding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Dose-response decrease in plasma tryptophan and in brain tryptophan and serotonin after tryptophan-free amino acid mixtures in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001920

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001920

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17160067%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference